229 related articles for article (PubMed ID: 24969092)
21. Bariatric Surgery in Patients with a History of Nephrolithiasis: 24-h Urine Profiles and Radiographic Changes After Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy.
Uy M; Di Lena R; Hoogenes J; Alharbi B; Gmora S; Shayegan B; Matsumoto ED
Obes Surg; 2021 Apr; 31(4):1673-1679. PubMed ID: 33387265
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.
DeFoor WR; Asplin JR; Kollar L; Jackson E; Jenkins T; Schulte M; Inge T
Surg Obes Relat Dis; 2016 Feb; 12(2):363-7. PubMed ID: 26077697
[TBL] [Abstract][Full Text] [Related]
23. Dyslipidaemia in overweight children and adolescents is associated with an increased risk of kidney stones.
Kirejczyk JK; Korzeniecka-Kozerska A; Baran M; Porowska H; Porowski T; Wasilewska A
Acta Paediatr; 2015 Sep; 104(9):e407-13. PubMed ID: 26096629
[TBL] [Abstract][Full Text] [Related]
24. Stone formation and management after bariatric surgery.
Tarplin S; Ganesan V; Monga M
Nat Rev Urol; 2015 May; 12(5):263-70. PubMed ID: 25850790
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors for Kidney Stone Formation following Bariatric Surgery.
Prochaska M; Worcester E
Kidney360; 2020 Dec; 1(12):1456-1461. PubMed ID: 34085046
[TBL] [Abstract][Full Text] [Related]
26. 24-h uric acid excretion and the risk of kidney stones.
Curhan GC; Taylor EN
Kidney Int; 2008 Feb; 73(4):489-96. PubMed ID: 18059457
[TBL] [Abstract][Full Text] [Related]
27. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
Huang HS; Ma MC; Chen CF; Chen J
Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
[TBL] [Abstract][Full Text] [Related]
28. Daily Green Tea Infusions in Hypercalciuric Renal Stone Patients: No Evidence for Increased Stone Risk Factors or Oxalate-Dependent Stones.
Rode J; Bazin D; Dessombz A; Benzerara Y; Letavernier E; Tabibzadeh N; Hoznek A; Tligui M; Traxer O; Daudon M; Haymann JP
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678344
[TBL] [Abstract][Full Text] [Related]
29. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
[TBL] [Abstract][Full Text] [Related]
30. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
31. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
Curhan GC; Willett WC; Speizer FE; Stampfer MJ
Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
[TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease and kidney stones.
Uribarri J
Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):237-242. PubMed ID: 31972597
[TBL] [Abstract][Full Text] [Related]
33. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
[TBL] [Abstract][Full Text] [Related]
34. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
Kumar R; Lieske JC; Collazo-Clavell ML; Sarr MG; Olson ER; Vrtiska TJ; Bergstralh EJ; Li X
Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
[TBL] [Abstract][Full Text] [Related]
35. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
36. Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors.
Kleinman JG
Kidney Int; 2007 Jul; 72(1):8-10. PubMed ID: 17597787
[TBL] [Abstract][Full Text] [Related]
37. Topiramate increases biochemical risk of nephrolithiasis.
Lamb EJ; Stevens PE; Nashef L
Ann Clin Biochem; 2004 Mar; 41(Pt 2):166-9. PubMed ID: 15025812
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Dietary Modifications and Medical Management on 24-Hour Urinary Metabolic Profiles and the Status of Renal Stone Disease in Recurrent Stone Formers.
Abu-Ghanem Y; Kleinmann N; Erlich T; Winkler HZ; Zilberman DE
Isr Med Assoc J; 2021 Jan; 23(1):12-16. PubMed ID: 33443336
[TBL] [Abstract][Full Text] [Related]
39. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.
Evan AP; Lingeman JE; Worcester EM; Bledsoe SB; Sommer AJ; Williams JC; Krambeck AE; Philips CL; Coe FL
Kidney Int; 2010 Aug; 78(3):310-7. PubMed ID: 20428098
[TBL] [Abstract][Full Text] [Related]
40. Urinary calculi and jejunoileal bypass operation. A long-term follow-up.
Annuk M; Backman U; Holmgren K; Vessby B
Scand J Urol Nephrol; 1998 May; 32(3):177-80. PubMed ID: 9689695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
